Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
about
Pathogenesis of systemic sclerosis-current concept and emerging treatments.A case report of open craniofacial sutures, a novel feature of systemic sclerosis?S100A9 aggravates bleomycin-induced dermal fibrosis in mice via activation of ERK1/2 MAPK and NF-κB pathways.Use of biologics and other novel therapies for the treatment of systemic sclerosis.Clinical significance of serum soluble T-cell immunoglobulin and mucin domain 3 levels in systemic sclerosis: Association with disease severity.A case series of imatinib-induced generalized hypopigmentation and progression of existing acquired dermal melanocytosis.Rapamycin Inhibits the Growth and Collagen Production of Fibroblasts Derived from Human Urethral Scar Tissue.NRF2 Activation Inhibits Both TGF-1- and IL-13-Mediated Periostin Expression in Fibroblasts: Benefit of Cinnamaldehyde for Antifibrotic Treatment
P2860
Q39294794-904404C0-39AA-4A7D-A51C-FE512E6E456AQ49714461-C2A8C280-DA01-4059-B49C-F3C1A8C360F1Q49874210-7251036F-E69C-4CD5-A8B9-399DF79E9B3DQ51297193-39691F5E-AD19-437E-977E-8EB037115173Q54520505-63EF1F58-A96E-4213-BDE5-7A63C7457BFCQ55000704-EB1AB7C1-B930-40FF-BB62-50E032C4EE08Q55031192-687B5B1B-CBF5-4512-8DC5-11AA2FB37DD0Q58796921-94EA5C6E-C2CF-4F1A-8332-C72791088649
P2860
Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
@en
type
label
Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
@en
prefLabel
Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
@en
P2860
P356
P1476
Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
@en
P2093
Koichi Yanaba
P2860
P356
10.1111/1346-8138.13026
P577
2016-01-01T00:00:00Z